HomeOGN • NYSE
add
Organon & Co
Nakaraang pagsara
$6.52
Sakop ng araw
$6.34 - $6.56
Sakop ng taon
$6.18 - $17.23
Market cap
1.68B USD
Average na Volume
5.78M
P/E ratio
2.41
Dividend yield
1.24%
Primary exchange
NYSE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.59B | -0.81% |
Gastos sa pagpapatakbo | 548.00M | -0.90% |
Net na kita | 145.00M | -25.64% |
Net profit margin | 9.10 | -24.98% |
Kita sa bawat share | 1.00 | -10.71% |
EBITDA | 425.00M | -5.97% |
Aktuwal na % ng binabayarang buwis | 36.68% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 599.00M | -14.91% |
Kabuuang asset | 13.50B | 11.07% |
Kabuuang sagutin | 12.77B | 6.30% |
Kabuuang equity | 733.00M | — |
Natitirang share | 259.97M | — |
Presyo para makapag-book | 2.31 | — |
Return on assets | 6.30% | — |
Return on capital | 8.78% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 145.00M | -25.64% |
Cash mula sa mga operasyon | 220.00M | -33.73% |
Cash mula sa pag-invest | -38.00M | 17.39% |
Cash mula sa financing | -223.00M | -66.42% |
Net change in cash | 52.00M | -59.69% |
Malayang cash flow | 91.12M | -60.79% |
Tungkol
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States. Wikipedia
Itinatag
1923
Headquarters
Website
Mga Empleyado
10,000
